Earlier release of Interim Report for January - June 2016
Zinzino hereby announces that the company will present the publication of the interim report for the period of January - June 2016, Friday the 26th of August at 13:00.
For more information, please contact: Dag Bergheim Pettersen, CEO of Zinzino, Tel. no.: +47(0) 93 22 57 00
For free to publish pictures, please contact: Anders Ekhammar, Tel. +46 (0) 707 462 579
Certified Adviser: Erik Penser Bank
The information presented here is such that Zinzino AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, on August 25, 2016.
Zinzino AB (publ), which is listed on OMX First North, is a direct sales company focussing on health products. The company markets and retails products within two product lines: Zinzino Health, which focuses on long-term health and accounts for approx. 70 percent of sales, and Zinzino Coffee, which sells espresso machines and accessories. Zinzino has a market presence across the EU, Norway and Iceland, as well as in the USA and Canada. Zinzino offers eco-friendly products with a focus on quality, health and a sense of everyday luxury. The company’s values are characterised by high quality, proximity to customers and active product development. Zinzino owns the Norwegian knowledge company BioActive Foods AS and the research and production unit Faun Pharma AS, which produces all of Zinzino Health’s products and all protein products for Proteinfabrikken. Since 2005, Zinzino has been a general agent for the Franco-Belgian coffee house Rombouts & Malongo. Zinzino forecasts a turnover of SEK 500 million for 2016. The Group has a head office in Gothenburg, a factory in Oslo, and offices in Helsinki, Oslo, Riga and Jupiter, Florida, and employs approximately 100 people.